119 related articles for article (PubMed ID: 28196708)
21. Dual β2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD.
Shan WJ; Huang L; Zhou Q; Jiang HL; Luo ZH; Lai KF; Li XS
Bioorg Med Chem Lett; 2012 Feb; 22(4):1523-6. PubMed ID: 22297114
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of 3,5-disubstituted-1,2,4-oxadiazoles as potent inhibitors of phosphodiesterase4b2.
Kumar D; Patel G; Vijayakrishnan L; Dastidar SG; Ray A
Chem Biol Drug Des; 2012 May; 79(5):810-8. PubMed ID: 22176507
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, and Biological Evaluation of Pyrazole Derivatives.
Hu C; Gao Y; Du W
Chem Biol Drug Des; 2016 May; 87(5):673-9. PubMed ID: 26648479
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors.
Kümmerle AE; Schmitt M; Cardozo SV; Lugnier C; Villa P; Lopes AB; Romeiro NC; Justiniano H; Martins MA; Fraga CA; Bourguignon JJ; Barreiro EJ
J Med Chem; 2012 Sep; 55(17):7525-45. PubMed ID: 22891752
[TBL] [Abstract][Full Text] [Related]
25. Pd-mediated functionalization of polysubstituted pyrroles: their evaluation as potential inhibitors of PDE4.
Bhaskar Kumar T; Sumanth Ch; Vaishaly S; Srinivasa Rao M; Chandra Sekhar KB; Meda CL; Kandale A; Rambabu D; Rama Krishna G; Malla Reddy C; Shiva Kumar K; Parsa KV; Pal M
Bioorg Med Chem Lett; 2012 Sep; 22(17):5639-47. PubMed ID: 22871579
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of 2,2,4-trimethyl-1,2-dihydroquinolinyl substituted 1,2,3-triazole derivatives: their evaluation as potential PDE 4B inhibitors possessing cytotoxic properties against cancer cells.
Praveena KS; Durgadas S; Suresh Babu N; Akkenapally S; Ganesh Kumar C; Deora GS; Murthy NY; Mukkanti K; Pal S
Bioorg Chem; 2014 Apr; 53():8-14. PubMed ID: 24463218
[TBL] [Abstract][Full Text] [Related]
27. Discovery of oxazole-based PDE4 inhibitors with picomolar potency.
Kuang R; Shue HJ; Xiao L; Blythin DJ; Shih NY; Chen X; Gu D; Schwerdt J; Lin L; Ting PC; Cao J; Aslanian R; Piwinski JJ; Prelusky D; Wu P; Zhang J; Zhang X; Celly CS; Billah M; Wang P
Bioorg Med Chem Lett; 2012 Apr; 22(7):2594-7. PubMed ID: 22401864
[TBL] [Abstract][Full Text] [Related]
28. Catecholic amides as potential selective phosphodiesterase 4D inhibitors: Design, synthesis, pharmacological evaluation and structure-activity relationships.
Zhou ZZ; Ge BC; Chen YF; Shi XD; Yang XM; Xu JP
Bioorg Med Chem; 2015 Nov; 23(22):7332-9. PubMed ID: 26526739
[TBL] [Abstract][Full Text] [Related]
29. Montmorillonite K-10 mediated green synthesis of cyano pyridines: Their evaluation as potential inhibitors of PDE4.
Ram Reddy T; Rajeshwar Reddy G; Srinivasula Reddy L; Jammula S; Lingappa Y; Kapavarapu R; Meda CL; Parsa KV; Pal M
Eur J Med Chem; 2012 Feb; 48():265-74. PubMed ID: 22217868
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of 4,5,6,7-tetrahydro-1H-1,2-diazepin-7-one derivatives as a new series of Phosphodiesterase 4 (PDE4) inhibitors.
Guariento S; Karawajczyk A; Bull JA; Marchini G; Bielska M; Iwanowa X; Bruno O; Fossa P; Giordanetto F
Bioorg Med Chem Lett; 2017 Jan; 27(1):24-29. PubMed ID: 27890378
[TBL] [Abstract][Full Text] [Related]
31. New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies.
Guariento S; Bruno O; Fossa P; Cichero E
Mol Divers; 2016 Feb; 20(1):77-92. PubMed ID: 26290462
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological activity of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors.
Taltavull J; Serrat J; Gràcia J; Gavaldà A; Córdoba M; Calama E; Montero JL; Andrés M; Miralpeix M; Vilella D; Hernández B; Beleta J; Ryder H; Pagès L
Eur J Med Chem; 2011 Oct; 46(10):4946-56. PubMed ID: 21871695
[TBL] [Abstract][Full Text] [Related]
33. Development of highly potent phosphodiesterase 4 inhibitors with anti-neuroinflammation potential: Design, synthesis, and structure-activity relationship study of catecholamides bearing aromatic rings.
Zhou ZZ; Ge BC; Zhong QP; Huang C; Cheng YF; Yang XM; Wang HT; Xu JP
Eur J Med Chem; 2016 Nov; 124():372-379. PubMed ID: 27597413
[TBL] [Abstract][Full Text] [Related]
34. Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidate.
Press NJ; Taylor RJ; Fullerton JD; Tranter P; McCarthy C; Keller TH; Arnold N; Beer D; Brown L; Cheung R; Christie J; Denholm A; Haberthuer S; Hatto JD; Keenan M; Mercer MK; Oakman H; Sahri H; Tuffnell AR; Tweed M; Tyler JW; Wagner T; Fozard JR; Trifilieff A
J Med Chem; 2012 Sep; 55(17):7472-9. PubMed ID: 22889281
[TBL] [Abstract][Full Text] [Related]
35. Montmorillonite K-10 catalyzed green synthesis of 2,6-unsubstituted dihydropyridines as potential inhibitors of PDE4.
Reddy TR; Reddy GR; Reddy LS; Meda CL; Parsa KV; Kumar KS; Lingappa Y; Pal M
Eur J Med Chem; 2013 Apr; 62():395-404. PubMed ID: 23380174
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological activity of pyrazole analogues of the staurosporine aglycon K252c.
Esvan YJ; Giraud F; Pereira E; Suchaud V; Nauton L; Théry V; Dezhenkova LG; Kaluzhny DN; Mazov VN; Shtil AA; Anizon F; Moreau P
Bioorg Med Chem; 2016 Jul; 24(14):3116-24. PubMed ID: 27255178
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and in vitro α-chymotrypsin inhibitory activity of 6-chlorobenzimidazole derivatives.
Siddiqui H; Farooq R; Marasini BP; Malik R; Syed N; Moin ST; Atta-Ur-Rahman ; Choudhary MI
Bioorg Med Chem; 2016 Aug; 24(16):3387-95. PubMed ID: 27374882
[TBL] [Abstract][Full Text] [Related]
38. Novel imidazophenoxazine-4-sulfonamides: their synthesis and evaluation as potential inhibitors of PDE4.
Reddy SV; Rao GM; Kumar BV; Meda CL; Deora GS; Kumar KS; Parsa KV; Pal M
Bioorg Med Chem; 2013 Apr; 21(7):1952-63. PubMed ID: 23415088
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, DFT study and antifungal activity of the derivatives of pyrazolecarboxamide containing thiazole or oxazole ring.
Yan Z; Liu A; Huang M; Liu M; Pei H; Huang L; Yi H; Liu W; Hu A
Eur J Med Chem; 2018 Apr; 149():170-181. PubMed ID: 29501939
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and evaluation of dual pharmacology β2-adrenoceptor agonists and PDE4 inhibitors.
Huang L; Shan W; Zhou Q; Xie J; Lai K; Li X
Bioorg Med Chem Lett; 2014 Jan; 24(1):249-53. PubMed ID: 24300734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
